StonvexLoading…
StonvexStonvexStonvexCore line items from TRNO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $128.75M | $124.44M | $476.38M | $338.90M | $222.65M |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $69.43M | $402.99M | $244.78M | $93.27M |
EPS (Diluted) | $0.38 | $0.66 | $3.91 | $2.38 | $1.38 |
Total Assets | Not available | $5.55B | $5.39B | $5.33B | $4.98B |
Total Liabilities | Not available | $1.26B | $1.24B | $1.33B | $1.04B |
Cash & Equivalents | Not available | $87.87M | $25.02M | $26.15M | $128.37M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 105.72M | 103.57M | 102.86M | 102.80M |